Acrobiosystems Co.,Ltd. (SHE:301080)
China flag China · Delayed Price · Currency is CNY
52.30
+7.30 (16.22%)
At close: Aug 4, 2026

Acrobiosystems Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
171.25165.57123.83153.59203.73174.21
Depreciation & Amortization
65.8565.8553.2542.0234.513.94
Other Amortization
22.2822.2819.0217.459.63.99
Loss (Gain) From Sale of Assets
-0.07-0.070.35--0.21-0.28
Asset Writedown & Restructuring Costs
4.114.11037.7624.225.7
Loss (Gain) From Sale of Investments
-10.57-10.571.48-5.37-21.63-8.1
Provision & Write-off of Bad Debts
-0.03-0.030.031.711.03-
Other Operating Activities
37.8337.0336.09-9.34-4.430.4
Change in Accounts Receivable
74.1574.15-41.23-56.05-17.64-26.27
Change in Inventory
-131.03-131.03-83.21-81.32-52.91-34.44
Change in Accounts Payable
135.69135.69-6.1429.8137.2217.4
Change in Other Net Operating Assets
11.611.6-6.37-5.937.251.18
Operating Cash Flow
362.22355.7484.71111.2202.19138.01
Operating Cash Flow Growth
320.75%319.97%-23.82%-45.00%46.51%43.02%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-221.4-205.08-167.26-128.69-284.29-61.7
Sale of Property, Plant & Equipment
1.211.214.7100.35-
Cash Acquisitions
---1.731.92--
Investment in Securities
-66.74-220.98276.980.19-913.61-722.05
Other Investing Activities
174.17104.710.125.2621.118.05
Investing Cash Flow
-112.76-320.14112.85-91.32-1,176-775.7

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
---6--
Long-Term Debt Issued
-55.2897.46---
Total Debt Issued
55.2855.2897.466--
Long-Term Debt Repaid
--110.85-42.78-31.93-17.61-9.54
Net Debt Issued (Repaid)
-19.47-55.5754.68-25.93-17.61-9.54
Issuance of Common Stock
--7.06-13.52,118
Repurchase of Common Stock
-23.85-23.85-12-10--
Common Dividends Paid
-47.99-85.55-108.21-120-120-
Other Financing Activities
-18-14.44----18.21
Financing Cash Flow
-109.31-179.42-58.48-155.93-124.112,090

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-6.57-7.767.6513.856.42-2.26
Net Cash Flow
133.57-151.59146.73-122.2-1,0921,450

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
140.82150.66-82.56-17.49-82.176.31
Free Cash Flow Growth
------6.39%
Free Cash Flow Margin
15.87%17.98%-12.80%-3.22%-17.30%19.82%
Free Cash Flow Per Share
0.850.90-0.49-0.10-0.490.57
Levered Free Cash Flow
-119.88-118.22-156.74-25.36-173.0141.41
Unlevered Free Cash Flow
-119.26-116.54-154.52-23.67-171.1742.13

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
84.0953.9760.5548.6736.4341.4
Change in Working Capital
71.5571.55-149.35-126.63-44.62-51.85